Vineeta Agarwala Biography
Vineeta Agarwala is a physician and a venture investor with a focus on biotech and health tech companies. She serves as a General Partner at Andreessen Horowitz and also serves on the board of BigHat Biosciences. She also works as an adjunct clinical professor in the Division of Primary Care and Population Health at Stanford.
Vineeta Agarwala Age
She was born in 1987.
Vineeta Agarwala Education
She holds a Bachelor of Science degree in Biophysics from Stanford University, and MD and PhD degrees from Harvard Medical School / MIT. She completed her clinical residency at Stanford and is board certified in internal medicine.
Vineeta Agarwala Husband
Vineeta is married to Parag Agrawal who was named Twitter CEO on November 29, 2021. He previously served as chief technology officer. He has been with the company for over a decade having worked his way up from n engineer to become its top executive.
He joined Twitter in October 2011 where he focused on n ad products, and he became the first recipient of the company’s “Distinguished Engineer” title. During his time as CTO, he oversaw Twitter’s decentralized Bluesky platform, which was first announced in December 2019. Intended as an “open and decentralized standard for social media” that Twitter itself could eventually transition to using.
Vineeta Agarwala Children
Together with her husband, they have a son known as Ansh Agrawal.
Vineeta Agarwala a16Z
Vineeta is a General Partner at Andreessen Horowitz where she leads investments for the firm’s bio fund across therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery. She serves on the board of BigHat Biosciences.
Prior to joining a16z, she held several roles in the healthcare space: as a physician taking care of patients, as an operator at tech-driven healthcare companies and as a venture investor on the GV (Google Ventures) life sciences team, focused on biotech companies with a data-driven approach. This broad mandate resulted in investments such as Maze Therapeutics (using human genomics for target discovery and validation), Locana (engineering RNA to treat disease), Spero Therapeutics (tackling antibiotic resistance), and more.
She has also worked as an early data scientist at Kyruus, a management consultant for biotech, pharmaceutical, and medical device clients at McKinsey & Co; and a Director of Product Management at Flatiron Health, where she led the company’s partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale database products to accelerate drug development and research in oncology.
She has collaborated with academic researchers at Cold Spring Harbor Laboratory, Lawrence Livermore National Laboratory, and the Broad Institute, where she did graduate work in computational biology and human genetics.
Vineeta Agarwala Flatiron Health
She worked as a director of product management at Flatiron Health, where she leads the development of national-scale databases that integrate clinical and genomic data for research and drug development in oncology.
The cancer-technology company collects clinical data from cancer patients, like medications patients have taken and how they responded to them, to aid understanding of how cancer drugs work in the “real world.”